Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects
Clinical trial NCT05272683 · COMPLETED
Trial details
- NCT number
- NCT05272683
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2022-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.